TWI686209B - Antibacterial cosmetic composition comprising lactobacillus plantarum culture - Google Patents

Antibacterial cosmetic composition comprising lactobacillus plantarum culture Download PDF

Info

Publication number
TWI686209B
TWI686209B TW107140823A TW107140823A TWI686209B TW I686209 B TWI686209 B TW I686209B TW 107140823 A TW107140823 A TW 107140823A TW 107140823 A TW107140823 A TW 107140823A TW I686209 B TWI686209 B TW I686209B
Authority
TW
Taiwan
Prior art keywords
culture
skin
lactobacillus
cjlp133
cosmetic composition
Prior art date
Application number
TW107140823A
Other languages
Chinese (zh)
Other versions
TW201922224A (en
Inventor
白世熙
徐溶基
辛民景
Original Assignee
南韓商Cj第一製糖股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南韓商Cj第一製糖股份有限公司 filed Critical 南韓商Cj第一製糖股份有限公司
Publication of TW201922224A publication Critical patent/TW201922224A/en
Application granted granted Critical
Publication of TWI686209B publication Critical patent/TWI686209B/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present application relates to an antibacterial cosmetic composition for skin comprising a Lactobacillus plantarum culture.

Description

包含胚芽乳酸桿菌培養物的抗菌化粧品組成物 Antibacterial cosmetic composition containing embryonic lactobacillus culture

本發明係關於一種具抗菌效果的化粧品組成物,其含有單一乳酸菌培養物,具體而言,係關於一種含有胚芽乳酸桿菌(Lactobacillus plantarum)CJLP133培養物的皮膚用抗菌化粧品組成物。 The present invention relates to a cosmetic composition having an antibacterial effect, which contains a single lactic acid bacteria culture, and in particular, to an antibacterial cosmetic composition for skin containing a culture of Lactobacillus plantarum CJLP133.

人體皮膚能保護身體免受各種氧化物、空氣污染、重金屬及紫外線(UV)等傷害,且能防止細菌、真菌及病毒等侵入皮膚,並扮演防止水分流失的保護屏障的角色。皮膚的結構大致分為三層之表皮、真皮和皮下脂肪,且該真皮層包含皮膚的90%,由膠原蛋白、彈性蛋白、玻尿酸和糖蛋白所組成。膠原蛋白係皮膚的主要成分,是一種重要的纖維蛋白,約佔人體蛋白質總重量的25%。膠原蛋白構成了大部分結締組織並扮演重要角色如細胞間基質功能、結構支持功能、誘導細胞分裂和分化、提供皮膚拉伸強度等。 Human skin can protect the body from various oxides, air pollution, heavy metals and ultraviolet (UV) damage, and can prevent bacteria, fungi and viruses from invading the skin, and plays a role as a protective barrier against water loss. The structure of the skin is roughly divided into three layers of epidermis, dermis and subcutaneous fat, and the dermis layer contains 90% of the skin and is composed of collagen, elastin, hyaluronic acid and glycoprotein. Collagen is the main component of the skin and is an important fibrous protein, accounting for about 25% of the total weight of human protein. Collagen constitutes most of the connective tissue and plays important roles such as intercellular matrix function, structural support function, induce cell division and differentiation, provide skin tensile strength and so on.

此外,已知從體內釋放的皮脂與汗液成分 中的脂肪酸、高級醇、蛋白質等,和化粧品成分會被存在於皮膚的皮膚菌群分解成毒性物質,從而引起皮膚發炎;進一步地,由於來自太陽光的紫外線損害了皮膚屏障,暴露於病原微生物引起的繼發感染誘發了各種皮膚病(例如,痤瘡、搔癢、皮膚炎、過敏等)。 In addition, it is known that fatty acids, higher alcohols, proteins, etc. in sebum and sweat components released from the body, and cosmetic components are decomposed into toxic substances by the skin flora present on the skin, causing skin inflammation; further, due to the sun The ultraviolet rays of light damage the skin barrier, and secondary infections caused by exposure to pathogenic microorganisms induce various skin diseases (eg, acne, itching, dermatitis, allergies, etc.).

因此,最大化化粧品中每種成分的效果並最小化其副作用以防止皮膚老化是非常重要的問題。在這方面,必須開發一種成本效益的材料,其抑制有害細菌生長且沒有副作用,以及一種含有該材料且方便使用的化粧品。 Therefore, it is a very important issue to maximize the effect of each ingredient in cosmetics and minimize its side effects to prevent skin aging. In this regard, it is necessary to develop a cost-effective material that inhibits the growth of harmful bacteria without side effects, and a cosmetic that contains the material and is convenient to use.

乳酸菌是一種藉由碳水化合物或纖維的發酵來產生乳酸,且在人體中具有益作用的細菌。到目前為止,已經發現了約400種乳酸菌,且已將約18個品種開發成商業產品。 Lactic acid bacteria are bacteria that produce lactic acid through the fermentation of carbohydrates or fiber and have beneficial effects in the human body. So far, about 400 kinds of lactic acid bacteria have been discovered, and about 18 varieties have been developed into commercial products.

一旦乳酸菌進入體內腸道,它們經由自身的代謝活性分泌特定的材料。由於這些材料對人體有益,因此已經對乳酸菌進行了許多研究。乳酸菌在抗菌、抗氧化劑和免疫活性的效果已經被報導。近年來,研究集中於乳酸菌的美白和保濕效果,且用作化粧品材料的可能性已經增加。在乳酸菌之中,已經對乳酸桿菌的效果進行許多研究,並且免疫力、抗菌效果、皮膚美白的增強、異位性皮膚炎的改善等已經被報導。 Once lactic acid bacteria enter the intestinal tract of the body, they secrete specific materials through their own metabolic activity. Because these materials are beneficial to the human body, many studies have been conducted on lactic acid bacteria. The effects of lactic acid bacteria on antibacterial, antioxidant and immune activity have been reported. In recent years, research has focused on the whitening and moisturizing effects of lactic acid bacteria, and the possibility of use as a cosmetic material has increased. Among the lactic acid bacteria, many studies have been conducted on the effects of Lactobacillus, and immunity, antibacterial effects, enhancement of skin whitening, improvement of atopic dermatitis, etc. have been reported.

其中,植物來源的乳酸菌(POLAB)是從植物原料的發酵食品(例如醃菜、泡菜等)中分離的乳酸菌,並 且和乳品來源的乳酸菌有所區別。 Among them, plant-derived lactic acid bacteria (POLAB) are lactic acid bacteria isolated from fermented foods of plant materials (such as pickles, kimchi, etc.), and are different from dairy-derived lactic acid bacteria.

與動物性乳酸菌相比,植物來源的乳酸菌不僅包括至少多10倍的類型,並且它們對外部環境具有極佳的適應性。特別是從泡菜中分離的植物性乳酸菌,其具有高含量的鹽、低pH值和高含量的天然抗菌材料,可以在極端環境中生長,因此植物來源的乳酸菌具有多種不同生理活性材料的優異生產力。 Compared with animal lactic acid bacteria, lactic acid bacteria of plant origin not only include at least 10 times more types, but they also have excellent adaptability to the external environment. Especially the plant-derived lactic acid bacteria isolated from kimchi, which have high content of salt, low pH and high content of natural antibacterial materials, can grow in extreme environments, so plant-derived lactic acid bacteria have excellent productivity of a variety of different physiologically active materials .

代表性的生理活性材料包括抗菌肽、免疫刺激劑、γ-胺基丁酸(GABA),其表現包括消炎和免疫抑制效果等各種生理功能。另外,乳酸菌是熱穩定肽,且產生作為抗菌劑的細菌素。細菌素是由各種微生物產生的天然抗微生物蛋白質或蛋白質材料,通常指稱具有針對細菌菌株的滅菌機制的材料,該細菌菌株在形態學和譜系學上類似於產生細菌素的微生物。因此,正在積極地開發使用含有這些材料的乳酸菌培養物或乳酸菌發酵植物萃取物的化粧品材料,且這個進展符合近期有利於環保和安全材料的趨勢。 Representative physiologically active materials include antimicrobial peptides, immunostimulants, γ-aminobutyric acid (GABA), and its performance includes various physiological functions such as anti-inflammatory and immunosuppressive effects. In addition, lactic acid bacteria are heat-stable peptides and produce bacteriocins as antibacterial agents. Bacteriocins are natural antimicrobial proteins or protein materials produced by various microorganisms, and are generally referred to as materials having a sterilization mechanism against bacterial strains that are similar in morphology and pedigree to bacteriocin-producing microorganisms. Therefore, cosmetic materials using lactic acid bacteria cultures or lactic acid bacteria fermented plant extracts containing these materials are being actively developed, and this progress is in line with the recent trend in favor of environmentally friendly and safe materials.

目前,消費者不僅期望化粧品中的一般照護效果,還需要各種不同功能(例如,抗老化、改良細紋、抗刺激、消炎、美白效果等)。 At present, consumers not only expect general care effects in cosmetics, but also various functions (eg, anti-aging, improved fine lines, anti-irritation, anti-inflammatory, whitening effects, etc.).

近年來,基於上述目的,已經將各種植物萃取物用於化粧品中,並且對以新概念為基礎之產品的期望越來越高,該新概念係藉由結合各種特性,顯示出改進的性能特徵範圍。 In recent years, based on the above purpose, various plant extracts have been used in cosmetics, and expectations for products based on new concepts are increasing. The new concept shows improved performance characteristics by combining various characteristics range.

[先前技術文獻] [Prior Technical Literature] [專利文獻] [Patent Literature]

[專利文獻1]KR10-1486999 B1(2015.01.21) [Patent Literature 1] KR10-1486999 B1 (2015.01.21)

為符合環保的時代,本發明的發明人已經努力研究來自泡菜的乳酸菌培養物的化粧品,該培養物對皮膚是安全而沒有任何副作用的,並且可以有效地經由抗菌活性用於抗菌護膚,此外,還要研究其在國內工業化中發展的可能性。其結果,發明人已經證實胚芽乳酸桿菌CJLP133培養物對皮膚具有抗菌活性,從而完成了本發明的內容。 In order to comply with the era of environmental protection, the inventors of the present invention have worked hard to study cosmetics from the culture of lactic acid bacteria of kimchi, which is safe for the skin without any side effects, and can be effectively used for antibacterial skin care via antibacterial activity. In addition, We must also study the possibility of its development in domestic industrialization. As a result, the inventors have confirmed that the culture of Lactobacillus germs CJLP133 has antibacterial activity on the skin, thus completing the content of the present invention.

本發明的目的係提供一種包含以登錄號KCTC 11403BP寄存的胚芽乳酸桿菌CJLP133培養物的皮膚用抗菌化粧品組成物,其中,該胚芽乳酸桿菌CJLP133的細菌體經移除。 The object of the present invention is to provide an antibacterial cosmetic composition for skin containing a culture of Lactobacillus germs CJLP133 deposited under the accession number KCTC 11403BP, in which the bacterial body of the Lactobacillus germs CJLP133 is removed.

本發明提供一種使用胚芽乳酸桿菌菌株(即,皮膚有益菌)製備胚芽乳酸桿菌CJLP133培養物的方法,該培養物對皮膚是安全且沒有任何副作用的,還提供一種具抗菌活性的化粧品組成物,其含有胚芽乳酸桿菌CJLP133培養物。 The present invention provides a method for preparing a Lactobacillus germ L. germ CJLP133 culture using a Lactobacillus germ strain (ie, beneficial skin bacteria), which is safe for the skin and does not have any side effects, and also provides a cosmetic composition with antibacterial activity, It contains a Lactobacillus germ CJLP133 culture.

第1圖係顯示胚芽乳酸桿菌CJLP133培養物的抗菌活性之實驗結果。2a:金黃色葡萄球菌,2b:表皮葡萄球菌,2c:大腸桿菌O157:H7型,2d:綠膿桿菌,和2e:痤瘡丙酸桿菌。 Figure 1 shows the experimental results of the antibacterial activity of L. germ CJLP133 culture. 2a: Staphylococcus aureus, 2b: Staphylococcus epidermidis, 2c: Escherichia coli O157: H7 type, 2d: Pseudomonas aeruginosa, and 2e: Propionibacterium acnes.

為達上述目的,本發明的一態樣為提供一種包含以登錄號KCTC 11403BP寄存的胚芽乳酸桿菌CJLP133培養物的皮膚用抗菌化粧品組成物,其中,該胚芽乳酸桿菌的細菌體經移除。 To achieve the above object, one aspect of the present invention is to provide an antibacterial cosmetic composition for skin containing a culture of Lactobacillus germs CJLP133 deposited under the accession number KCTC 11403BP, in which the bacterial bodies of the Lactobacillus germs are removed.

在下文中,詳細解釋了本發明所提供含有胚芽乳酸桿菌培養物的皮膚用抗菌化粧品組成物。 In the following, the antibacterial cosmetic composition for skin containing a culture of Lactobacillus germs provided by the present invention is explained in detail.

在本文中,術語「胚芽乳酸桿菌」是指一種乳酸桿菌屬的微生物,其是一種能夠製造乳酸的革蘭氏陰性細菌。該細菌係可在發酵食品如酸菜、醃菜、泡菜等中發現。 As used herein, the term "Lactobacillus germ" refers to a microorganism of the genus Lactobacillus, which is a Gram-negative bacterium capable of producing lactic acid. The bacterial system can be found in fermented foods such as sauerkraut, pickles, and kimchi.

胚芽乳酸桿菌菌株,尤指胚芽乳酸桿菌CJLP133菌株,其是以登錄號KCTC 11403BP寄存的菌株。 The Lactobacillus germ strain, in particular the Lactobacillus germ strain CJLP133, is a strain deposited with accession number KCTC 11403BP.

具體而言,胚芽乳酸桿菌CJLP133菌株係以登錄號KCTC 11403BP於2008年10月16日寄存於韓國生命科學及生物技術研究院(KRIBB)的韓國微生物保存中心(KCTC),該組織是布達佩斯條約下的國際保存機構。 Specifically, the Lactobacillus germ CJLP133 strain was deposited with the accession number KCTC 11403BP at the Korea Microbiological Preservation Center (KCTC) of the Korea Institute of Life Sciences and Biotechnology (KRIBB) on October 16, 2008. The organization is under the Budapest Treaty International depository.

在本文中,術語「培養物」是指含有在培養基中培養微生物菌株時產生的副產物的培養基,其中, 該菌株允許攝入和代謝培養基所含之營養物。術語「培養物」包括所有使用培養基可形成的調配物(例如,培養基的稀釋物或濃縮物、藉由乾燥培養基獲得的乾燥產物、培養基的粗製物或純化產物、其等之混合物等)。 As used herein, the term "culture" refers to a culture medium containing by-products produced when culturing a microorganism strain in a culture medium, wherein the strain allows ingestion and metabolism of nutrients contained in the culture medium. The term "culture" includes all formulations that can be formed using a culture medium (for example, a dilution or concentrate of the culture medium, a dried product obtained by drying the culture medium, a crude or purified product of the culture medium, a mixture of these, etc.).

具體而言,培養物可為藉由通過培養胚芽乳酸桿菌CJLP133菌株所獲得者,或者可為藉由培養菌株所獲得者,其中,該細菌體在培育後經移除。也就是說,其中該細菌體經移除的培養基可以使用作為培養物。 Specifically, the culture may be obtained by cultivating the Lactobacillus germ L. strain CJLP133, or may be obtained by culturing the strain, wherein the bacterial body is removed after incubation. That is, the medium in which the bacterial body is removed can be used as a culture.

更具體而言,培養物可以下述方法獲得,該方法包括:(a)藉由接種培養基來培養胚芽乳酸桿菌CJLP133菌株;(b)離心(a)步驟所得之產物;以及(c)從(b)步驟所得之產物回收上澄部分。 More specifically, the culture can be obtained by a method including: (a) culturing the Lactobacillus germ L. CJLP133 strain by inoculating a medium; (b) centrifuging the product obtained in step (a); and (c) from ( b) The product obtained in the step is recovered to Shangcheng part.

在(a)步驟中,培養基可以是本領域中所使用的任何培養基,只要該培養基可以培育菌株,並在培育後回收培養物,具體地為液體培養基,更具體地為MRS液體培養基。 In the step (a), the medium may be any medium used in the art, as long as the medium can cultivate strains, and the culture is recovered after the cultivation, specifically a liquid medium, more specifically an MRS liquid medium.

為了獲得純的分離菌株,步驟(a)可進一步包括在步驟(a)之前,平板培養胚芽乳酸桿菌菌株在固體培養基及培養並收集菌落的步驟,其中,該菌落被證實為純的分離菌株。 In order to obtain a pure isolated strain, step (a) may further include a step of culturing and collecting colonies of the embryo Lactobacillus strains on a solid medium before step (a), wherein the colonies are confirmed to be pure isolated strains.

在步驟(b)中,係使用高速離心機在1℃至7℃離心,具體地為2℃至6℃,更具體地為3℃至5℃;旋轉速率為1,500rpm至3,500rpm,具體地為2,000rpm至3,000rpm,更具體地為2,200rpm至2,800rpm;進行10至 30分鐘,具體地為15至25分鐘,更具體地為17至23分鐘。 In step (b), a high-speed centrifuge is used to centrifuge at 1°C to 7°C, specifically 2°C to 6°C, more specifically 3°C to 5°C; the rotation rate is 1,500 rpm to 3,500 rpm, specifically 2,000 rpm to 3,000 rpm, more specifically 2,200 rpm to 2,800 rpm; performed for 10 to 30 minutes, specifically 15 to 25 minutes, more specifically 17 to 23 minutes.

步驟(c)可進一步包括過濾上澄部分的步驟。此外,步驟(c)可進一步包括另一步驟,該步驟係使用冷凍乾燥機將過濾後的上澄液粉末化。 Step (c) may further include the step of filtering the Shangcheng portion. In addition, step (c) may further include another step of powdering the filtered supernatant liquid using a freeze dryer.

在本文中,術語「抗菌」係指抑制微生物(例如,與皮膚病相關的細菌)生長的效果。 In this context, the term "antibacterial" refers to the effect of inhibiting the growth of microorganisms (eg, bacteria associated with skin diseases).

本發明中,培養物針對選自下述所成群組的至少一細菌可具有抗菌活性:金黃色葡萄球菌、表皮葡萄球菌、大腸桿菌O157:H7型、綠膿桿菌及痤瘡丙酸桿菌,但不以該等為限。 In the present invention, the culture may have antibacterial activity against at least one bacterium selected from the group consisting of Staphylococcus aureus, Staphylococcus epidermidis, E. coli O157: H7, Pseudomonas aeruginosa, and Propionibacterium acnes, but Not limited to these.

此外,經由抗菌活性,本發明的組成物可為可改善藉由微生物所誘發的皮膚疾病者。 In addition, through the antibacterial activity, the composition of the present invention can improve the skin diseases induced by microorganisms.

在本文中,術語「改良」係指使用本發明的組成物遏止或抑制由細菌所引起的皮膚病症狀,或減輕已經出現在皮膚的皮膚病症狀。 As used herein, the term "improvement" refers to the use of the composition of the present invention to suppress or suppress the symptoms of skin diseases caused by bacteria, or to alleviate the symptoms of skin diseases that have already appeared on the skin.

在本發明中,化粧品組成物可調配為下述形式:溶液、外用軟膏、乳膏、泡沫、營養護膚霜、柔軟護膚霜、敷料、軟水、乳液、打底霜、香精、肥皂、液體清潔劑、沐浴劑、防曬霜、防曬油、懸浮液、乳化物、糊、凝膠、洗劑、粉末、肥皂、含界面活性劑的清潔劑、油、粉狀粉底、乳化粉底、蠟狀粉底、貼片及噴霧,但調配物以該等為限。 In the present invention, the cosmetic composition can be formulated into the following forms: solution, external ointment, cream, foam, nutritional skin cream, soft skin cream, dressing, soft water, lotion, primer, fragrance, soap, liquid cleanser , Bathing agent, sunscreen, sunscreen oil, suspension, emulsion, paste, gel, lotion, powder, soap, detergent with surfactant, oil, powder foundation, emulsified foundation, wax foundation, paste Tablets and sprays, but the formulations are limited to these.

在本發明中,化粧品組成物可進一步含有 至少一種化粧品可接受的載劑,該載劑係用來加入一般的皮膚化粧品。作為化粧品可接受載劑的常規組分,例如可以適當地混合油、水、界面活性劑、保濕劑、低級醇、增稠劑、螯合劑、色素、防腐劑、香料等,但該組分不以該等為限。 In the present invention, the cosmetic composition may further contain at least one cosmetically acceptable carrier, which is used to add general skin cosmetics. As a conventional component of a cosmetically acceptable carrier, for example, oil, water, surfactants, humectants, lower alcohols, thickeners, chelating agents, colors, preservatives, perfumes, etc. can be appropriately mixed, but the component is not Subject to these.

加入本發明的化粧品組成物之化粧品可接受載劑,可以根據化粧品組成物的調配物而改變。 The cosmetically acceptable carrier added to the cosmetic composition of the present invention can be changed according to the formulation of the cosmetic composition.

當本發明的調配物為軟膏、糊、乳膏或凝膠等時,作為載劑組分可以使用動物油、植物油、蠟、石蠟、澱粉、紫雲英樹膠、纖維素衍生物、聚乙二醇、矽氧樹指、皂土、二氧化矽、滑石、氧化鋅等,但該載劑組分不以該等為限。該載劑組分可以單獨或以兩種以上組合使用。 When the formulation of the present invention is an ointment, paste, cream or gel, etc., as the carrier component, animal oil, vegetable oil, wax, paraffin, starch, aspartame, cellulose derivative, polyethylene glycol, silicon Oxygen finger, bentonite, silica, talc, zinc oxide, etc., but the carrier component is not limited to these. The carrier component may be used alone or in combination of two or more.

當本發明的調配物為粉末或噴霧時,作為載劑組分可以使用乳糖、滑石、二氧化矽、氫氧化鋁、矽酸鈣、聚醯胺粉末等;特別在使用噴霧的情況下,調配物可以進一步含有推進劑,例如氯氟烴、丙烷/丁烷和二甲醚,但該載劑組成不以該等為限。該載劑組分可以單獨或以兩種以上的組合使用。 When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder, etc. can be used as a carrier component; especially when a spray is used, the formulation The substance may further contain propellants such as chlorofluorocarbons, propane/butane and dimethyl ether, but the composition of the carrier is not limited to these. The carrier component can be used alone or in combination of two or more.

當本發明的調配物為溶液或乳化物時,作為載劑組成可以使用溶劑、助溶劑或乳化劑(例如,水、乙醇、異丙醇、碳酸乙基酯、乙酸乙酯、苯甲醇、苯甲酸芐酯、丙二醇、1,3-丁二醇油等),及特別可使用棉籽油、花生油、玉米籽油、橄欖油、蓖麻油、芝麻油、甘油脂肪族 酯、聚乙二醇或去水山梨醇脂肪酸酯,但該載劑組分不以該等為限。該載劑組分可以單獨或以兩種以上的組合使用。 When the formulation of the present invention is a solution or an emulsified product, a solvent, co-solvent or emulsifier (for example, water, ethanol, isopropyl alcohol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzene) can be used as a carrier composition Benzyl formate, propylene glycol, 1,3-butanediol oil, etc.), and especially cottonseed oil, peanut oil, cornseed oil, olive oil, castor oil, sesame oil, glycerin aliphatic ester, polyethylene glycol or dehydrated Sorbitol fatty acid ester, but the carrier component is not limited to these. The carrier component can be used alone or in combination of two or more.

當本發明的調配物為懸浮液時,作為載劑成分可以使用液體稀釋劑(例如,水、乙醇或丙二醇)、懸浮劑(例如,乙氧化異硬脂醇、山梨糖醇聚氧乙烯酯和脫水山梨糖醇聚氧乙烯酯)、微晶型纖維素、羥基氧化鋁、皂土、瓊脂、紫雲英樹膠等,但載劑組分不以該等為限。該載劑組分可以單獨或以兩種以上的組合使用。 When the formulation of the present invention is a suspension, as the carrier component, a liquid diluent (for example, water, ethanol, or propylene glycol), a suspending agent (for example, ethoxylated isostearyl alcohol, sorbitol polyoxyethylene ester, and Sorbitan polyoxyethylene ester), microcrystalline cellulose, aluminum oxyhydroxide, bentonite, agar, aspartame, etc., but the carrier component is not limited to these. The carrier component can be used alone or in combination of two or more.

當本發明的調配物為肥皂時,作為載劑組分可以使用脂肪酸的鹼金屬鹽、脂肪酸的半酯鹽、脂肪酸蛋白質水解物、羥乙基磺酸、羊毛酯衍生物、脂肪族醇、植物油、甘油、醣類等,但載劑組分不以該等為限。該載劑組分可以單獨或以兩種以上的組合使用。 When the formulation of the present invention is soap, as the carrier component, alkali metal salts of fatty acids, half-ester salts of fatty acids, fatty acid protein hydrolysates, isethionic acid, lanolin derivatives, aliphatic alcohols, vegetable oils can be used , Glycerin, sugars, etc., but the carrier component is not limited to these. The carrier component can be used alone or in combination of two or more.

本發明的另一方面為提供一種皮膚用的抗菌方法,該方法係對個體施用一種其中細菌體經移除的胚芽乳酸桿菌培養物。 Another aspect of the present invention is to provide an antibacterial method for skin, which method is to apply an Lactobacillus germ of embryo culture in which a bacterial body is removed to an individual.

皮膚用的抗菌方法可為包括對需要抗菌皮膚的個體施用一種含有胚芽乳酸桿菌培養物,及額外地化粧品可接受載劑的化粧品組成物。該化粧品可接受的載劑係如上文所述。 The antibacterial method for skin may include applying a cosmetic composition containing an Lactobacillus germ culture to an individual in need of antibacterial skin, and additionally a cosmetically acceptable carrier. The cosmetically acceptable carrier is as described above.

個體可能包括也可不包括人類。具體而言,個體可以是哺乳動物,包括牛、豬、羊、雞、狗人類等;鳥類等,且可包括但不限於藉由施用上述組成物而具有抗菌活性的任何個體者。 Individuals may or may not include humans. Specifically, the individual may be a mammal, including cows, pigs, sheep, chickens, dogs, humans, etc.; birds, etc., and may include, but is not limited to, any individual who has antibacterial activity by administering the above composition.

本發明的另一方面為提供了一種組成物之用途,其係用於製備含有胚芽乳酸桿菌培養物的具抗菌活性化粧品,其中,該胚芽乳酸桿菌的細菌體經移除。 Another aspect of the present invention is to provide the use of a composition for preparing an antibacterially active cosmetic containing a culture of Lactobacillus germ, wherein the bacterial body of the Lactobacillus germ is removed.

後文中,將參考下述實施例更詳細揭示本發明內容。惟,對本發明所屬技術領域者,此等實施例係僅用於例示性說明之目的,且本發明不欲為此等實施例所限。 Hereinafter, the content of the present invention will be disclosed in more detail with reference to the following examples. However, for those skilled in the art, these embodiments are for illustrative purposes only, and the present invention is not intended to be limited to these embodiments.

實施例1:製備胚芽乳酸桿菌CJLP133培養物Example 1: Preparation of LJ germ CJLP133 culture

將以登錄號KCTC 11403BP寄存的胚芽乳酸桿菌CJLP133菌株平板培養在固體MRS培養基(BD Difco,乳酸桿菌屬MRS瓊脂),並在37℃培養約18小時。確認之後,收集純的分離菌落並使用鉑環接種到液態MRS培養基(BD Difco,乳酸桿菌屬MRS broth),並在37℃培養大約18小時。培養完成後,培養物濃度為1.0×109CFU/mL。為了將細菌體從培養物中分離,該培養物在4℃及2,500rpm的條件下使用高速離心機(LABOGENE 1248R)離心20分鐘。過濾該培養物的上澄部分之後,使用冷凍乾燥機(HETO PL90000)將過濾後的上澄部分粉末化。由此方法製備成的培養物稱為「胚芽乳酸桿菌CJLP133培養物」 The Lactobacillus sp. CJLP133 strain deposited under the accession number KCTC 11403BP was plated on a solid MRS medium (BD Difco, Lactobacillus MRS agar), and cultured at 37°C for about 18 hours. After confirmation, pure isolated colonies were collected and inoculated into a liquid MRS medium (BD Difco, Lactobacillus MRS broth) using a platinum ring, and cultured at 37°C for about 18 hours. After the cultivation is completed, the culture concentration is 1.0×10 9 CFU/mL. In order to separate the bacterial body from the culture, the culture was centrifuged at 4°C and 2,500 rpm for 20 minutes using a high-speed centrifuge (LABOGENE 1248R). After filtering the upper portion of the culture, the filtered upper portion was powdered using a freeze dryer (HETO PL90000). The culture prepared by this method is called "Lactobacillus germ L. CJLP133 culture"

實施例2:確認胚芽乳酸桿菌CJLP133培養物的抗菌活性Example 2: Confirmation of the antibacterial activity of the Lactobacillus germ CJLP133 culture

為了確認實施例1所製備的胚芽乳酸桿菌CJLP133培養物針對皮膚病原體的抗菌活性,以圓盤擴散法測量有關皮膚病原體的抑制圈。 In order to confirm the antibacterial activity of the Lactobacillus sp. CJLP133 culture prepared in Example 1 against skin pathogens, the inhibition circle of the skin pathogens was measured by the disk diffusion method.

總共使用五種皮膚病原體菌株,金黃色葡萄球菌、表皮葡萄球菌、大腸桿菌O157:H7型、綠膿桿菌和痤瘡丙酸桿菌,其等經常在皮膚中檢測到。所有這五種皮膚病原體菌株均係來自韓國生命科學及生物技術研究所(KRIBB)的韓國微生物保存中心(KCTC)。每種菌株的登錄號、培養基、培養溫度和育成時間的細節如下表1所示。 A total of five skin pathogen strains are used, Staphylococcus aureus, Staphylococcus epidermidis, E. coli O157: H7 type, Pseudomonas aeruginosa and Propionibacterium acnes, which are often detected in the skin. All five strains of skin pathogens come from the Korea Microbiological Preservation Center (KCTC) of the Korea Institute of Life Science and Biotechnology (KRIBB). The details of the accession number, culture medium, culture temperature and incubation time of each strain are shown in Table 1 below.

使用氣體包裝系統(三菱瓦斯化學株式會社,厭氧產氣袋)將痤瘡丙酸桿菌密封在厭氧培養罐中,並厭氧地培養。 Using a gas packaging system (Mitsubishi Gas Chemical Co., Ltd., anaerobic gas-producing bag), P. acnes was sealed in an anaerobic culture tank and cultivated anaerobicly.

Figure 107140823-A0202-12-0011-2
Figure 107140823-A0202-12-0011-2

作為對照組,使用材料係經由冷凍乾燥法將液體MRS培養基粉碎之後加入無菌蒸餾水製備至濃度0.5g/mL而製備。作為試驗組,使用材料係藉由添加無菌蒸餾水到胚芽乳酸桿菌CJLP133培養物至濃度0.1g/mL、0.5g/mL及2.5g/mL而製備。 As a control group, a material system was prepared by pulverizing a liquid MRS medium via a freeze-drying method and adding sterile distilled water to a concentration of 0.5 g/mL. As a test group, the materials used were prepared by adding sterile distilled water to the culture of Lactobacillus germ L. CJLP133 to a concentration of 0.1 g/mL, 0.5 g/mL, and 2.5 g/mL.

將每種皮膚病原體菌株以1.6×106CFU/mL的濃度接種在培養基(TSA;BD Difco,胰蛋白酶大豆瓊脂,RCM;BD Difco,強化梭菌培養基)。將無菌紙圓盤(ADVANTEC,8mm)放置在其中每種菌株經平板培養的平板上後,分別添加50μL的試驗材料及對照材料。根據各自的培養條件(表1)培養每個菌株後,測量圓盤周圍抑制圈(即,指示菌株的凋亡區域)的直徑。較大的抑制圈表示抗菌活性較佳,且在沒有抗微生物活性下不會形成抑制圈。 Each strain of skin pathogen was inoculated in a medium (TSA; BD Difco, tryptic soy agar, RCM; BD Difco, enhanced Clostridium medium) at a concentration of 1.6×10 6 CFU/mL. After placing a sterile paper disc (ADVANTEC, 8 mm) on a plate in which each strain was cultured on a plate, 50 μL of the test material and the control material were added respectively. After cultivating each strain according to the respective culture conditions (Table 1), the diameter of the inhibition circle around the disc (ie, the area of apoptosis indicating the strain) was measured. A larger inhibition circle indicates that the antibacterial activity is better, and the inhibition circle will not be formed without antimicrobial activity.

試驗結果顯示,對照組沒有形成抑制圈,而使用胚芽乳酸桿菌CJLP133培養物的試驗組在五種菌株中皆形成了抑制圈,從而證實了胚芽乳酸桿菌CJLP133培養物具有對皮膚病原體的抗菌活性。此外,隨著胚芽乳酸桿菌CJLP133培養物濃度的增加,抑制圈的尺寸亦增加,從而證實了抗菌活性是以濃度依賴性的方式增加。試驗結果如表2及第1圖所示。 The test results showed that the control group did not form an inhibitory circle, while the test group using the Lactobacillus germs CJLP133 culture formed inhibition circles in all five strains, thus confirming that the Lactobacillus germs CJLP133 culture had antibacterial activity against skin pathogens. In addition, as the concentration of L. germ CJLP133 culture increased, the size of the suppression circle also increased, confirming that the antibacterial activity increased in a concentration-dependent manner. The test results are shown in Table 2 and Figure 1.

Figure 107140823-A0202-12-0013-3
Figure 107140823-A0202-12-0013-3

根據這些結果可以發現胚芽乳酸桿菌CJLP133菌株的培養物具有抗菌活性,因此可用於皮膚抗菌。 Based on these results, it can be found that the culture of the Lactobacillus germ L. CJLP133 strain has antibacterial activity, and thus can be used for skin antibacterial.

本發明所屬技術領域者能夠自前述內容理解,本發明可藉由其他具體形式例式之而不改變本街露內容之技術概念或本質特徵。就此而言,本文中揭露之例示性態樣係僅用於例示性說明之用,且不應解釋為限制本揭露內容之範疇。反之,本揭露內容係傾向於不僅涵蓋該等例示性態樣,亦涵蓋可包括於如後所附申請專利範圍定義者之本發明內容之精神及範疇內的多種變更、修飾、均等物、及其他態樣。 Those skilled in the art of the present invention can understand from the foregoing content that the present invention can be modified by other specific forms without changing the technical concept or essential characteristics of the content disclosed in this street. In this regard, the illustrative aspects disclosed herein are for illustrative purposes only and should not be construed as limiting the scope of this disclosure. On the contrary, this disclosure tends to cover not only these exemplary features, but also various changes, modifications, equivalents, and the like that can be included within the spirit and scope of the present invention as defined by the appended patent application scope, and Other aspects.

【生物材料寄存】【Biological Material Storage】 國外寄存資訊【請依寄存國家、機構、日期、號碼順序註記】 Overseas hosting information [Please note in order of hosting country, institution, date, number]

大韓民國、韓國微生物保存中心、2008年10月09日、KCTC11403BP。 Republic of Korea, Korea Microbiological Preservation Center, October 09, 2008, KCTC11403BP.

Claims (2)

一種皮膚用抗菌化粧品組成物,其包含以登錄號KCTC 11403BP寄存的胚芽乳酸桿菌CJLP133培養物,其中,該胚芽乳酸桿菌CJLP133的細菌體經移除,其中,該培養物針對選自下述所成群組之至少一細菌具有抗菌活性:表皮葡萄球菌、大腸桿菌O157:H7型及痤瘡丙酸桿菌。 An antibacterial cosmetic composition for skin, comprising a culture of Lactobacillus germ L. CJLP133 deposited under the accession number KCTC 11403BP, wherein the bacterial body of the Lactobacillus germ L. CJLP133 is removed, wherein the culture is directed to At least one bacterium in the group has antibacterial activity: Staphylococcus epidermidis, E. coli O157: H7 type and Propionibacterium acnes. 如申請專利範圍第1項所述的化粧品組成物,其中,該培養物係以包括下述之方法獲得:(a)藉由接種培養基來培養胚芽乳酸桿菌CJLP133菌株;(b)將(a)步驟所得之產物離心;以及(c)從(b)步驟所得之產物回收上澄部分。 The cosmetic composition as described in item 1 of the patent application scope, wherein the culture is obtained by a method including the following: (a) cultivating the Lactobacillus germs CJLP133 strain by inoculating a medium; (b) replacing (a) The product obtained in the step is centrifuged; and (c) the product obtained in the step (b) is recovered in the upper part.
TW107140823A 2017-11-16 2018-11-16 Antibacterial cosmetic composition comprising lactobacillus plantarum culture TWI686209B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020170153344A KR102032546B1 (en) 2017-11-16 2017-11-16 Cosmetic comoposition for antibacterial comprising Lactobacillus plantarum culture
KR10-2017-0153344 2017-11-16
??10-2017-0153344 2017-11-16

Publications (2)

Publication Number Publication Date
TW201922224A TW201922224A (en) 2019-06-16
TWI686209B true TWI686209B (en) 2020-03-01

Family

ID=66540345

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107140823A TWI686209B (en) 2017-11-16 2018-11-16 Antibacterial cosmetic composition comprising lactobacillus plantarum culture

Country Status (4)

Country Link
KR (1) KR102032546B1 (en)
CN (1) CN111601584A (en)
TW (1) TWI686209B (en)
WO (1) WO2019098752A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102199934B1 (en) * 2019-06-26 2021-01-08 한국식품연구원 Cosmetic compositions containing Hwangryunhaedoktang fermented with Lactobacillus plantarum WiKim0111 for anti-acne
KR102350437B1 (en) * 2019-06-26 2022-01-14 한국식품연구원 Cosmetic compositions containing Hwangryunhaedoktang fermented with Lactobacillus plantarum WiKim0111 for anti-acne
JP7383120B2 (en) * 2020-02-13 2023-11-17 シージェイ チェイルジェダン コーポレーション Composition for improving skin condition
KR102343239B1 (en) * 2020-05-13 2021-12-23 피부생명공학센터 주식회사 Novel strain of Lactobacillus plantarum having antimicrobial effect against pathogenic microorganism infection
CN112159781A (en) * 2020-10-23 2021-01-01 深圳市沁帆科技有限公司 Lactobacillus plantarum, microbial agent and application thereof
KR102263479B1 (en) 2020-12-30 2021-06-10 주식회사 닥터제이코스 Cosmetic composition for anti-aging comprising heat-killed Lactobacillus plantarum or culture of the Lactobacillus plantarum
KR102457367B1 (en) * 2021-09-30 2022-10-24 한국식품연구원 Lactobacillus plantarum wikim0126 strain derived from jeju pickled brussels sprout food and method for preparing composition using same
KR102457366B1 (en) * 2021-09-30 2022-10-21 한국식품연구원 Lactobacillus plantarum wikim0127 strain derived from jeju pickled cabbage food and method for preparing composition using same
KR20230061273A (en) 2021-10-27 2023-05-08 씨제이바이오사이언스 주식회사 Composition for the prevention, improvement, or treatment of inflammatory skin diseases comprising a strain of the genus Cutibacterium
WO2023075431A1 (en) 2021-10-27 2023-05-04 씨제이바이오사이언스 주식회사 Cosmetic composition for prevention or improvement of inflammatory skin diseases comprising strain of genus cutibacterium
CN116103181A (en) * 2021-11-11 2023-05-12 中国科学院微生物研究所 Lactobacillus plantarum from human scalp and application thereof
CN114657106B (en) * 2022-04-21 2023-11-21 青岛蔚蓝生物股份有限公司 Lactobacillus plantarum and application thereof in preventing and treating acne
CN114574408B (en) * 2022-05-06 2022-07-22 山东锦鲤生物工程有限公司 Probiotic SEUNEU-107 and application
CN114672443B (en) * 2022-05-07 2024-04-05 青岛蔚蓝生物集团有限公司 Lactobacillus plantarum with functions of preventing or improving facial redness and type I rose acnes
KR102606325B1 (en) * 2022-11-15 2023-12-04 주식회사 큐옴바이오 Composition for antibacterial and skin disease improvement against skin harmful bacteria containing lactobacillus plantarum q1 strain
CN116286543B (en) * 2023-04-14 2023-07-21 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) Staphylococcus epidermidis with good moisturizing, whitening, anti-inflammatory, antioxidant and anti-aging effects and application thereof
KR102653020B1 (en) * 2023-09-26 2024-04-01 (주) 옵트바이오 A cosmetic composition containing fermented extract of Lactiplantibacillus plantarum OPT-antiUV strain

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016144139A2 (en) * 2015-03-11 2016-09-15 주식회사 엠디헬스케어 Composition for preventing or treating inflammatory diseases, comprising lactic acid bacteria-derived extracellular vesicles as active ingredients

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100720815B1 (en) * 2005-01-04 2007-05-21 장해춘 Lactobacillus plantarum AF1 with antifungal properties isolated from kimchi, and products produced by using them
KR101486999B1 (en) 2009-07-22 2015-01-28 씨제이제일제당 주식회사 Novel lactobacillus plantarum and compositions comprising the same
KR101287126B1 (en) * 2011-10-28 2013-07-17 대상에프앤에프 주식회사 Pharmaceutical compositon prevention and treatment of vaginitis and urinary tract infection comprising fermented solution of plant-originated Lactic acid bacteria
KR101442083B1 (en) * 2012-08-17 2014-09-19 주식회사 바이오셀트란 Cosmetic composition with culture meida of Latobacillus plantarum as antiseptic or functional component
FR2999601B1 (en) * 2012-12-17 2015-01-30 Urgo Lab METHOD FOR PREVENTING AND / OR TREATING INFECTIONS, COLONIZATIONS OR DISEASES ASSOCIATED WITH STAPHYLOCOCCUS AUREUS, PSEUDOMONAS AERUGINOSA, STREPTOCOCCUS PYOGENES, ENTEROCOCCUS FAECIUM, ENTEROBACTER CLOACAE, PROTEUS MIRABILIS AND / OR BACTEROIDES FRAGILIS
KR101636014B1 (en) * 2014-07-24 2016-07-04 수원대학교산학협력단 Lactobacillus sp. having anti-viral and anti-bacterial activity and use thereof
JP6788966B2 (en) * 2015-12-24 2020-11-25 丸善製薬株式会社 Cosmetics
KR101655774B1 (en) * 2016-02-19 2016-09-09 대한민국 Lactobacillus plantarum KCC-19 and composition comprising the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016144139A2 (en) * 2015-03-11 2016-09-15 주식회사 엠디헬스케어 Composition for preventing or treating inflammatory diseases, comprising lactic acid bacteria-derived extracellular vesicles as active ingredients

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SURGICAL INFECTIONS,Vol.18,no.2,2017 *
SURGICAL INFECTIONS,Vol.18,no.2,2017。

Also Published As

Publication number Publication date
WO2019098752A1 (en) 2019-05-23
TW201922224A (en) 2019-06-16
CN111601584A (en) 2020-08-28
KR102032546B1 (en) 2019-10-15
KR20190056177A (en) 2019-05-24

Similar Documents

Publication Publication Date Title
TWI686209B (en) Antibacterial cosmetic composition comprising lactobacillus plantarum culture
TWI734048B (en) Cosmetic composition for improving skin wrinkles comprising lactobacillus plantarum culture
US20170224750A1 (en) Lactobacillus plantarum cncm i-4026 preparations and skin health
KR102194315B1 (en) Antioxidant or skin microbiome balance cosmetic composition comprising centella asiatica fermented extract fermented by inoculating lactobacillus rhamnosus strain
KR101911078B1 (en) Composition for improving acneform skin conditions Comprising Complex Extracts of Swallow's Nest as Active Ingredient
KR20220092787A (en) A novel Lactobacillus paracasei strain and uses thereof
KR102031359B1 (en) Composition for improving microbial flora containing extract of Rosae Multiflorae fructus
KR102252855B1 (en) Cosmetic composition comprising nano-ized lactobacillus genus dead cells and a method for producing the same
KR102155716B1 (en) A carrot fermentation method using lactobacillus plantarum ami-1103 strain
KR102009604B1 (en) Antimicrobial composition comprising lonicera japonica extract and magnolia obovata extract
KR102001238B1 (en) Composition for improving microbial flora containing extract of Benincasa hispida Cogniaux
KR102001241B1 (en) Composition for improving microbial flora containing extract of Coicis Semen
KR101803148B1 (en) An antibacterial composition comprising the extract or fraction of Sargassum serratifolium
KR102390839B1 (en) Staphylococcus-derived antibacterial substance mixture against Staphylococcus aureus and uses thereof
KR20190050358A (en) Composition for improving microbial flora containing extract of violae herba
KR102001237B1 (en) Composition for improving microbial flora containing extract of Dolichoris Semen
KR20190050364A (en) Composition for improving microbial flora containing extract of Trigonellae semen
KR20190050350A (en) Composition for improving microbial flora containing extract of cinnamomi ramulus
KR102600167B1 (en) Novel Latilactobacillus sakei subsp. sakei M21F010 strain, and uses thereof
KR102001244B1 (en) Composition for improving microbial flora containing extract of Carthami Fructus
KR20190048881A (en) Composition for improving microbial flora containing extract of Persicae Semen
KR102001240B1 (en) Composition for improving microbial flora containing extract of Mori folium
KR102031361B1 (en) Composition for improving microbial flora containing extract of Lepidii seu Descurainiae semen
KR20240083000A (en) Cosmetic composition for maintaining microbiome balance in the skin comprising extract of brewer's yeast and 1,3-propanediol
KR20190050361A (en) Composition for improving microbial flora containing extract of Allii Fistulosi bulbus